Navigation Links
Biologicals in Medical News

Sanofi Pasteur Enters Agreement With Crucell for Next-Generation Biologicals Against Rabies

Exclusive Agreement for Rabies Monoclonal Antibodies to Fight Fatal Disease LYON, France, January 3 /PRNewswire-FirstCall/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it has signed an exclusive collaboration and commercialization agreement with Crucell ...

BioInformatics, LLC New Report - Exploring the Epigenetics Market: Opportunities for Product Placement and Innovations

...sher Scientific) Miltenyi Biotech Millipore (NYSE: MIL ) Molecular Probes (Life Technologies) NeoMarkers (Thermo Fisher Scientific) Novus biologicals Pierce (Thermo Fisher Scientific) Promega Quantum Dot (Life Technologies (Invitrogen)) R&D Systems (division of TECHNE Corp., Nasdaq: ...

Group B Strep Screening Guidelines Sparing Newborns

...rresponded with further declines in the incidence of early-onset GBS [group B strep] disease." Van Dyke is now an epidemiologist at GlaxoSmithKline biologicals in Rixensart, Belgium, although that company played no part in this study, which appears in the June 18 issue of the New England Journal of Medicine ...

3 studies confirm the value of etanercept therapy in treating juvenile idiopathic arthritis

... chronic arthritis in children, frequently results in physical disabilities and chronic pain influencing daily life. The results for the Arthritis and biologicals in Children project show impressive improvement on all domains of Health-Related Quality of Life impaired by JIA during treatment with etanercept. Thi...

Senate Bill to Protect Patients' Healthcare by Amending Medicare Coverage

...e-saving cancer treatments." This bill will amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under Part B of the Medicare Program. It excludes customary prompt pay discounts extended to wholesalers from the manufacturer's Average Sales Price ...

Dieter Luetticken Award 2008 Recognizes Development of New Vaccine Quality Control Assay

...of laboratory animals as well as studies aimed at reducing or avoiding the use of animals in efficacy, safety and quality testing in the production of biologicals and pharmaceuticals for animals. The award is named after Dr. Dieter Luetticken, a committed researcher in microbiology and virology. He has guid...

EXT Life Sciences Announces New Biotech Treatment that Tackles Root Cause of Graying Hair

... EXT is a Michigan-based biotechnology company engaged in developing, manufacturing, and selling new classes of proprietary, targeted antioxidant biologicals to prevent, treat and cure diseases associated with aging in the global pharmaceutical and cosmeceutical markets. EXT, founded in 2004, was initially...

House Bill to Improve Accuracy of Medicare Reimbursement Introduced: Members of Congress Seek to Stem Growing Healthcare Coverage Shortfalls, Community Oncology Alliance Advocates for Swift Passage of Bill

...today introduced H.R. 1392. This bill will amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's Average Sales Price (...

MedPredict Publishes Two New Reports Providing Expert Analysis of Malignant Hematology Drug Development

...ill change clinical practice," according to Jeff Berk, MedPredict president. "A key emphasis of this report is transplant, and how pharmaceuticals and biologicals better prepare patients for transplant. Our thought leader panel discusses how to achieve complete responses, how they are thinking about combination ...

Novel Lung Cancer Vaccine Trial Launched at Moores UCSD Cancer Center

...School of Medicine. "The future treatments for advanced lung cancer may involve combinations of chemotherapy and targeted agents, and possibly even biologicals such as this," she said. Roughly 430 patients die of lung cancer every day in the United States, according to Bazhenova, making it the nation's nu...
Biologicals in Medical Technology

Landmark Study for GSK's Cervical Cancer Vaccine Published in The Lancet

... Clinical R&D and Chief Medical Officer of GSK biologicals commented: "These excellent study results confirm ...to detect through screening. GlaxoSmithKline biologicals -- GSK Biologicals, GlaxoSmithKline's vaccines ...more in development. Headquartered in Belgium, GSK biologicals has 13 manufacturing sites strategically positione...

Malaria Vaccine Developer, Sanaria Inc., Receives 2009 Vaccine Industry Excellence Award for Best Early-Stage Vaccine Biotech

.... Sanaria was named Best Early-Stage Vaccine Biotech from a group of nine companies shortlisted for the award. Other awardees included GlaxoSmithKline biologicals for Best Vaccine R&D Pipeline and Merck for Best Prophylactic Vaccine. "This award caps a remarkable period of rapid progress and success in ...

Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS

...announced the results of a first clinical trial where the VE Patch was combined with an injectable H5N1 influenza vaccine, also manufactured by Solvay biologicals B.V. The data revealed that a single 45-microgram dose of the H5N1 influenza vaccine, when administered with the Intercell VE Patch containing 50-micr...

Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference

...he mosquito-borne malaria parasite. "These are all tools that need to be used together," he said. The RTS,S vaccine, developed by GlaxoSmithKline biologicals with support from the Malaria Vaccine Initiative of PATH (Program for Appropriate Technology in Health), is the first of 70 experimental malaria vacci...

Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa

...or more information, please visit http://www.ihi.or.tz . About GSK biologicals GlaxoSmithKline -- one of the world's leading research-based pharma...r company information, please visit http://www.gsk.com/media . GSK biologicals (GSK Bio), one of the world's leading vaccine manufacturers, is headquarter...

GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval

...any information, please visit http://www.gsk.com/media . GlaxoSmithKline biologicals (GSK Biologicals) is a leading global vaccine manufacturer committed to pre...ccines currently available globally and 20 more in development. In 2007 GSK biologicals distributed 1.1 billion doses of vaccines -- an average of 3 million doses ...

New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma

...year worldwide, and approximately 1.1 million deaths occur annually around the world.(6) About GlaxoSmithKline and GlaxoSmithKline Biologicals GSK biologicals (GSK Bio), one of the world's leading vaccine manufacturers, is headquartered in Rixensart, Belgium, where the majority of GlaxoSmithKline's activitie...

CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date

...lity of human life by enabling people to do more, feel better and live longer. For company information, please visit http://www.gsk.com/media . GSK biologicals (GSK Bio), one of the world's leading vaccine manufacturers, is headquartered in Rixensart, Belgium, where the majority of GlaxoSmithKline's activitie...

GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years

...lity of human life by enabling people to do more, feel better and live longer. For company information, please visit http://www.gsk.com/media . GSK biologicals (GSK Bio), one of the world's leading vaccine manufacturers, is headquartered in Rixensart, Belgium, where the majority of GlaxoSmithKline's activitie...

New Data Published in The Lancet Show GSK's ROTARIX(R) Offers Protection Against the Most Common Circulating Rotavirus Types

...cal and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. GSK biologicals (GSK Bio), one of the world's leading vaccine manufacturers, is headquartered in Rixensart, Belgium, where the majority of GlaxoSmithKline's activitie...
Biologicals in Biological News

VaxInnate to discuss seasonal and pandemic flu vaccines during BIO 2008 this week

...9th "Vaccine Renaissance," 8:30-10:00 am, Room 29A including Dr. Robert Becker "Moore's Law for Biomanufacturing: Innovation in a Maturing biologicals Industry," 4:00 - 5:30 pm, Room 29B including Edward Arcuri, PhD, VaxInnate's Chief of Operations (COO) VaxInnate's Approach VaxInnate's n...
Biologicals in Biological Technology

Novavax Reports Second Quarter 2009 Financial Results

...hich is targeted for 2012. Raised $21.9 million from the sale of 7.4 million shares of common stock through the ATM program. Launched CPL biologicals Pvt. Ltd, the previously announced joint venture with Cadila Pharmaceuticals, to develop and manufacture vaccines, biological therapeutics and diagnos...

Cadila Pharmaceuticals Launches Joint Venture With Novavax in India

...ies in March 2009. This joint venture, called CPL biologicals Pvt. Ltd., will develop and manufacture vaccines, ...avax and Cadila Pharmaceuticals. In addition, CPL biologicals will establish manufacturing facilities in India a...virus-like-particle (VLP) vaccine technology. CPL biologicals also expects to develop the pandemic H1N1 influenz...

AFFiRiS AG: 1st Place in Venture Capital & Private Equity Awards for MIG Fonds and AFFiRiS

...tal of euro 11.5 million. Without this capital, our licensing deal with GSK biologicals three years later would not have been possible. This deal is for up to euro... studies. In October 2008, the company succeeded in gaining GlaxoSmithKline biologicals as its licensing partner for the Alzheimer's vaccine. The contract anticipa...

AFFiRiS AG: Atherosclerosis Vaccine Development Receives EU Support

...censing agreement worth EUR 430 million that we recently concluded with GSK biologicals regarding the rights for the technology for our Alzheimer's vaccine program... studies. In October 2008, the company succeeded in gaining GlaxoSmithKline biologicals as its licensing partner for the Alzheimer's vaccine. The contract foresees...

Pharma and Biotech Companies Plug into Singapore's Integrated Research Network

...panies to test and develop new solutions for Asia and beyond. Recent announcements of public-private partnerships (PPP) include GlaxoSmithKline biologicals committing US$1.3 million in vaccine and process development with Singapore's Bioprocessing Technology Institute (BTI); Lilly Singapore Centre for Dru...

Caliper Life Sciences Reports First Quarter 2009 Results

... of the proprietary LabChip GX, which the Company believes is the "best-in-class" proprietary solution for characterizing proteins in the fast growing biologicals market, and increased sales of Profiler Pro reagent kits which are used for kinase screening with the EZ Reader instrument. Optical Imagin...

CERVARIX(R) U.S. Regulatory Update

...erous lesions are diagnosed. GlaxoSmithKline biologicals - GSK's vaccines business is one of the world's l...more in development. Headquartered in Belgium, GSK biologicals has 13 manufacturing sites strategically positioned around the globe. In 2008 GSK biologicals distributed 1.1 billion doses of vaccines to 176 c...

French Agency AMP Appoints Dr Kamel Senouci as Director of SIVAC Initiative (Supporting Independent Immunization and Vaccine Advisory Committees)

...f national immunization technical advisory groups is one of WHO's priority" said Dr Philippe Duclos,Senior Health Adviser - Immunization, Vaccines and biologicals at WHO, Geneva. "This is part of the process to ensure evidence-based decision-making at country level, which is particularly needed in view of the co...

Micromet Enters Into Agreement for Solid Tumor BiTE Antibody with Bayer Schering Pharma AG

...y technology by a major oncology company," said Christian Itin, Micromet's Chief Executive Officer. "Oncology is one of our core growth areas and biologicals are a key focus of our strategy. We are excited about Micromet's BiTE antibody technology and believe BiTE antibodies represent a novel and promising...

SCRIP, the Leading Pharmaceutical Magazine in the World Crowns Glenmark as the "Best Pharma Company in the World - SME" and the "Best Company in Emerging Markets" at the SCRIP Awards 2008 in London

...omenon!" said Dr. Viren Mehta.' The article further mentioned, 'While no company swept the board in 2008, Glenmark Pharmaceuticals and GlaxoSmithKline biologicals were the night's biggest winners, each garnering two awards.' Mr. Glenn Saldanha, MD & CEO, Glenmark Pharmaceuticals limited who was prese...
Biologicals in Biological Products

Rabbit Anti-HPRT Polyclonal Antibody, Unconjugated from Novus Biologicals

Description: ...
Company:

Mouse Anti-hnRNP F / H Monoclonal Antibody, Unconjugated, Clone 1G11 from Novus Biologicals

Description: ...
Company:

Rabbit Anti-Human Histone H3, acetyl Polyclonal Antibody, Unconjugated from Lake Placid Biologicals

Description: Antibody specific for histone H3 acetylated at any of the five N-terminal lysine residues. Rabbit polyclonal serum. Antigen: Synthetic peptide derived from histone H3 N-terminal region, mulitpliy acetylated...
Company:Lake Placid Biologicals

Rabbit Anti-Human Histone H3, phospho (Ser10 / Ser28) Polyclonal Antibody, Unconjugated from Lake Placid Biologicals

Description: Antibody specific for phosphorylattion of histone H3 that occurs during mitosis. Rabbit polyclonal serum. Antigen: Synthetic peptides derived from histone H3, phosphorylated at serines 10 or 28...
Company:Lake Placid Biologicals

Mouse Anti-Human Histone H3, trimethyl (Lys27) Monoclonal Antibody, Unconjugated from Lake Placid Biologicals

Description: Antibody specific for trimethyl-Lys27 of histone H3. Mouse monoclonal. Antigen: Synthetic peptide derived from histone H3, trimethylated at lysine 27...
Company:Lake Placid Biologicals

Rat Complement from Pel-Freez Biologicals

Description: Mature rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and processed within 45 minutes. It is then filtered through gauze, pooled in an ice bath, bottled, and frozen at -70C....
Company:Pel-Freez Biologicals

Pig Serum Non-Sterile Trace-Hemolyzed from Pel-Freez Biologicals

Description: Whole blood is collected from healthy pigs (mixed breed, either sex) at the time of slaughter, refrigerated within 6 hours, processed within 24 hours and frozen at -20ºC....
Company:Pel-Freez Biologicals

Rat Serum Non-Sterile Non-Hemolyzed from Pel-Freez Biologicals

Description: Rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and refrigerated within 6 hours, and processed and frozen within 24 hours. The serum is later thawed, pooled, bottled and frozen at -20?C....
Company:Pel-Freez Biologicals

Dog Serum Non-Sterile Trace-Hemolyzed from Pel-Freez Biologicals

Description: Whole blood is collected from canines (any breed, either sex), refrigerated within 6 hours, processed within 24 hours and frozen at -20C....
Company:Pel-Freez Biologicals

Rat Serum Non-Sterile Trace-Hemolyzed from Pel-Freez Biologicals

Description: Rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and refrigerated within 6 hours, and processed and frozen within 24 hours. The serum is later thawed, pooled, bottled and frozen at -20?C....
Company:Pel-Freez Biologicals

More>>

Other Tags
(Date:8/1/2014)... 2014 As AndroGel lawsuits and testosterone ... E. Johnson, Jr. has been appointed as co-lead counsel ... testosterone medications. Since the Fall of 2013, Ron and ... diligently to investigate and prosecute the claims of men ... clots as a result of taking testosterone. As a ...
(Date:8/1/2014)... 01, 2014 Growing prevalence of ... healthcare reforms are boosting healthcare market growth, although ... discounts and increasing generic consumption is a major ... million in 2013, having grown at a Compound ... The implementation of the Health Transformation Program (Saglikta ...
(Date:8/1/2014)... August 01, 2014 The "Antimicrobial ... such as Zinc Oxide, Titanium Dioxide, and Zinc ... & Construction, Food & Beverages, Textiles, and others), ... - Global Trends and Forecasts to 2018" analyzes ... drivers, opportunities, and trends in the diverse geographical ...
(Date:8/1/2014)... According to new market research ... North America, Europe, & ROW), by Vehicle Type ... (Gasoline & Diesel), by After-Treatment Device (DPF, DOC, ... Forecasts to 2019", defines and segments the global ... major countries in all the regions, and estimates ...
(Date:8/1/2014)... The Cardiovascular Research Foundation (CRF) has announced ... will be presented at next month,s Transcatheter Cardiovascular ... premier educational meeting specializing in interventional cardiovascular medicine, ... at the Walter E. Washington Convention Center in ... TCT often direct the course of patient therapies. ...
Breaking Medicine News(10 mins):Health News:Ron Johnson Named Co-Lead Counsel in Lawsuits for Men Injured by AndroGel and Testosterone 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 3Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 4Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 2Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 3Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 4Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 4Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 2Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 3Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 4
(Date:8/1/2014)... of the most diverse families in the ocean today ... -- originated more than 400 million years ago in ... those of its modern members. This Geology ... published online on 25 July 2014, tracks the remarkable ... , At is origin, the Lucinidae family remained at ...
(Date:8/1/2014)... a more effective way to control the condition, thanks ... National University of Singapore (NUS). , The team, led ... Pharmacology at the NUS Yong Loo Lin School of ... PhD graduate from the Saw Swee Hock School of ... herbal-based anti-malarial drug, can be used to control asthma, ...
(Date:8/1/2014)... two Simon Fraser University research associates, cite new ... collaborate closely on minimizing damage to the natural ... Maureen Ryan, David H. Smith Conservation Research Fellows ... international co-authors of the newly published research in ... , Shale gas development is the extraction of ...
Breaking Biology News(10 mins):Symbiotic survival 2Symbiotic survival 3Symbiotic survival 4Symbiotic survival 5Symbiotic survival 6Symbiotic survival 7Symbiotic survival 8Symbiotic survival 9Symbiotic survival 10Symbiotic survival 11Symbiotic survival 12Symbiotic survival 13Symbiotic survival 14NUS study shows effectiveness of common anti-malarial drug in controlling asthma 2Scientists warn time to stop drilling in the dark 2Scientists warn time to stop drilling in the dark 3
Other Contents